REFERENCES
- Adami HO, Norlén BJ, Malker B, Meirik O. Long-term survival in prostatic carcinoma, with special reference to age as a prognostic factor. Scand J Urol Nephrol 1986; 20: 107–112.
- Carlsson P, Hjertberg H, Jönsson B, Varenhorst E. The cost of prostatic cancer in a defined population. CMT Discussion Paper 1987: 2, Linköping University, 1987: 29–31.
- Carlsson P. Spridning och ekonomiska effekter av medicinsk teknologi–Vid behandling av magsår, prostataförstoring och gallsten (Diffusion and economic effects of medical technology–In treatment of peptic ulcer, prostatic hyperplasia and gallbladder disease). (Diss.) Linköping Studies in Art and Science, No 12, Linköping University, 1987: 50–52.
- Finansdepartmentet. Integrering av sjukvård och sjukförsäkring (Integration of health care and health insurance). DsFi 1987: 11, Stockholm, 1987.
- Henriksson P, Edhag O. Cost-effectiveness comparison of estrogen therapy and orchidectomy in patients with prostatic cancer. Intl J of Technology Assessment in Health Care 1987; 3: 523–529.
- Socialstyrelsen. En studie av allmän, ortopedisk och urologisk kirurgi (A study of general, orthopedic and urological surgery). National Board of Health and Welfare, pm 52/83, Stockholm, 1983.
- Socialstyrelsen. Cancer incidence in Sweden 1983. Stockholm: Liber Förlag, 1986.
- SCB. Causes of deaths 1985. National Bureau of Statistics, Stockholm, 1986.
- Varenhorst E, Wallentin L, Risberg B. Clotting predisposition in carcinoma of the prostate. J Urol 1981; 126: 419.